In conclusion, we provided evidences in this study that cisplatin pretreatment can enhance transduction of AAV in HNSCC cells, up-regulate TRAIL expression mediated by AAV, and inhibit tumor cell growth in vitro. This evidence concerns the gene TNFSF10 and head and neck squamous cell carcinoma.